Anavex Life Sciences AVXL
NASDAQ AVXL
$1.82 -0.07 (-3.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Other Accumulated Expenses (2020 - 2025)

Updated

Anavex Life Sciences (AVXL) posted Other Accumulated Expenses of $1.71 million for fiscal Q4 2025 (quarter ended Sep 30, 2025), down 9.5% from $1.89 million a year earlier and down 16.3% from the prior quarter.

Analysis

Anavex Life Sciences (AVXL) Other Accumulated Expenses (2020 - 2025) Analysis & Trends

Since fiscal Q4 2020, Anavex Life Sciences has reported Other Accumulated Expenses for 18 quarters.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
  • In prior fiscal years, Anavex Life Sciences' Other Accumulated Expenses was $1.89 million in FY2024 (-27.9%), $2.62 million in FY2023 (+27.3%), $2.06 million in FY2022 (+19.4%) and $1.73 million in FY2021 (+6.6%).
  • Quarterly Other Accumulated Expenses has run from a low of $1.53 million in fiscal Q2 2024 to a high of $2.62 million in fiscal Q4 2023 over five years.
  • On a year-over-year basis, Other Accumulated Expenses increased in three of the last eight quarters, with an average decline of 7.2%.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was fiscal Q4 2023, with growth of 27.3%; the weakest was fiscal Q4 2024, with a decline of 27.9%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior fiscal quarters was $2.05 million (Q3 2025), $1.56 million (Q2 2025) and $2.52 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Anavex Life Sciences 168.71 Mn -311.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.71 Mn
Jun 30, 2025 2.05 Mn
Mar 31, 2025 1.56 Mn
Dec 31, 2024 2.52 Mn
Sep 30, 2024 1.89 Mn
Jun 30, 2024 2.28 Mn
Mar 31, 2024 1.53 Mn
Dec 31, 2023 2.09 Mn
Sep 30, 2023 2.62 Mn
Jun 30, 2023 2.15 Mn
Mar 31, 2023 1.96 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.06 Mn
Jun 30, 2022 2.05 Mn
Mar 31, 2022 1.79 Mn
Dec 31, 2021 2.20 Mn
Sep 30, 2021 1.73 Mn
Sep 30, 2020 1.62 Mn
API Access

Anavex Life Sciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AVXL&period=max&api_key=YOUR_API_KEY